SS Innovations International Inc. (NASDAQ: SSII) announced record first-quarter 2026 financial results, underscoring accelerating commercial adoption of its SSi Mantra surgical robotic platform. Revenue for the quarter reached $11.1 million, a 116.8% increase year over year, driven primarily by higher system installations and increased procedure volumes. Gross profit rose to $5.3 million from $1.1 million in the same period last year.
The company reported that the installed base of SSi Mantra systems grew to 194 across 11 countries, with cumulative robotic procedures nearing 9,750. As of June 22, 2026, the cumulative number of procedures had risen to 11,719, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Additionally, approximately 2,100 physicians have been trained on the system, which has been used for over 170 different types of procedures.
SS Innovations also highlighted significant regulatory progress during the quarter, receiving approvals in Sri Lanka, Kenya, Indonesia, and the Philippines, further expanding its international market access. The company continues to pursue regulatory clearance in both the United States and Europe, which could open larger markets.
In a demonstration of its technological capabilities, SS Innovations recently completed the world’s longest-distance robotic cardiac telesurgery, showcasing the potential of its remote surgery platform. This achievement underscores the company's focus on enabling surgical care in underserved regions.
For more information, visit the company’s website at www.SSInnovations.com.
InvestorWire, a specialized communications platform, distributed this press release. For more details, see the full terms of use and disclaimers on the InvestorWire website at https://www.InvestorWire.com/Disclaimer.
